Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Do Positive Lateral Biopsy Cores on TRUS Directed Biopsies Predict Capsular Penetration and Positive Surgical Margins?

NCT00513721 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT00513721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00513721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Do Positive Lateral Biopsy Cores on TRUS Directed Biopsies Predict Capsular Penetration and Positive Surgical Margins?
Lead sponsor
Corewell Health East
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
May 31, 2009
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer